Search results for " hemoglobin"

showing 10 items of 204 documents

Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 and Ghrelin Levels in Patients with Type 2 Diabetes: A Prospective Pilot Study

2014

Abstract Context: Liraglutide is a glucagon-like peptide-1 analog and glucose-lowering agent whose effects on cardiovascular risk markers have not been fully elucidated. Objective: We evaluated the effect of liraglutide on markers of oxidative stress, heme oxygenase-1 (HO-1), and plasma ghrelin levels in patients with type-2 diabetes mellitus (T2DM). Design and Setting: A prospective pilot study of 2 months' duration has been performed at the Unit of Diabetes and Cardiovascular Prevention at University of Palermo, Italy. Patients and Intervention(s): Twenty subjects with T2DM (10 men and 10 women; mean age: 57 ± 13 y) were treated with liraglutide sc (0.6 mg/d for 2 wk, followed by 1.2 mg/d…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismClinical Biochemistry030209 endocrinology & metabolismContext (language use)Pilot ProjectsType 2 diabetes030204 cardiovascular system & hematologymedicine.disease_causeBiochemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyGlucagon-Like Peptide 1Internal medicineDiabetes mellitusMedicineHumansHypoglycemic AgentsProspective StudiesAgedbusiness.industryLiraglutideBiochemistry (medical)Liraglutide Heme oxygenase Lipid peroxidation Ghrelin Type-2 diabetesOriginal ArticlesLiraglutideMiddle Agedmedicine.diseaseGhrelinMetformin3. Good healthMetforminOxidative StressEndocrinologychemistryDiabetes Mellitus Type 2GhrelinDrug Therapy CombinationFemaleGlycated hemoglobinbusinessOxidative stressHeme Oxygenase-1medicine.drug
researchProduct

Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus

1999

To evaluate oxidative stress in type I diabetes mellitus, two antioxidant enzymes in erythrocytes, copper-zinc superoxide dismutase (SOD EC 1.15.1.1.) and seleno-dependent glutathione peroxidase (GSH-Px; EC 1.11.19), and two indexes of peroxidation in plasma, thiobarbituric acid reactive substances (TBARS) and organic hydroperoxides (OHP), were measured in 118 patients with insulin-dependent diabetes mellitus (IDDM), classified in accordance with the presence or absence of vascular complications and the degree of metabolic control established by the HbA1c level. Ninety healthy subjects made up the control group. According to our results, plasmatic TBARS and OHP concentrations are significan…

AdultMalemedicine.medical_specialtyErythrocytesAntioxidantThiobarbituric acidmedicine.medical_treatmentClinical BiochemistryThiobarbituric Acid Reactive SubstancesAntioxidantsLipid peroxidationchemistry.chemical_compoundInternal medicineDiabetes mellitusmedicineTBARSHumansTriglyceridesGlycated Hemoglobinchemistry.chemical_classificationGlutathione PeroxidaseSuperoxide DismutaseCholesterolGlutathione peroxidaseGeneral MedicineMiddle Agedmedicine.diseasePeroxidesOxidative StressCholesterolDiabetes Mellitus Type 1EndocrinologychemistryMetabolic control analysisRegression AnalysisFemaleLipid PeroxidationScandinavian Journal of Clinical and Laboratory Investigation
researchProduct

Association of reduced glyoxalase 1 activity and painful peripheral diabetic neuropathy in type 1 and 2 diabetes mellitus patients

2013

Abstract Aims The present study was undertaken to investigate the relationship between glyoxalase 1 (Glo1) enzyme activity and painful diabetic neuropathy (DN) in patients with diabetes mellitus. Methods Glo1 activity and biochemical markers were determined in blood samples from 108 patients with type 1 diabetes, 109 patients with type 2 diabetes, and 132 individuals without diabetes as a control. Painful and painless peripheral DN was assessed and multivariate regression analysis was used to determine independent association of Glo1 activity with occurrence of painful DN. Results In patients with type 1 and type 2 diabetes mellitus and painful DN compared to patients with painless DN, Glo1…

AdultMalemedicine.medical_specialtyMultivariate analysisEndocrinology Diabetes and MetabolismPainType 2 diabetesSeverity of Illness IndexGastroenterologyEndocrinologyDiabetic NeuropathiesInternal medicineDiabetes mellitusInternal MedicinemedicineHumansPain MeasurementGlycated HemoglobinType 1 diabetesbusiness.industryConfoundingLactoylglutathione LyasePeripheral Nervous System DiseasesType 2 Diabetes MellitusMiddle Agedmedicine.diseasePeripheralDiabetes Mellitus Type 1EndocrinologyDiabetes Mellitus Type 2Painful diabetic neuropathyDisease ProgressionFemalebusinessBiomarkersJournal of Diabetes and its Complications
researchProduct

Defining normality in a European multinational cohort: Critical factors influencing the 99th percentile upper reference limit for high sensitivity ca…

2015

To establish and critically evaluate the 99th percentile upper reference limit (URL) for high-sensitivity cardiac troponin I (hs-cTnI) in a large healthy European cohort using different selection criteria.1368 presumably healthy individuals from 9 countries were evaluated with surrogate biomarkers for diabetes (glycated hemoglobin [HbA1c]48 mmol/mol), myocardial (B-type natriuretic peptide [BNP]35 pg/mL) and renal dysfunction (estimated glomerular filtration rate [eGFR]60 mL/min/1.73 m(2)), and dyslipidemia to refine the healthy cohort. The 99th percentile URLs were independently determined by the non-parametric and robust methods.The use of biomarker selection criteria resulted in a decrea…

AdultMalemedicine.medical_specialtyPercentileSensitivity and SpecificityCohort Studieschemistry.chemical_compoundReference ValuesInternal medicineHumansMedicineMyocardial infarctionUnivariate analysisbusiness.industryPatient SelectionTroponin IMiddle Agedmedicine.diseaseConfidence intervalEuropeEndocrinologychemistryCohortFemaleGlycated hemoglobinCardiology and Cardiovascular MedicinebusinessBody mass indexBiomarkersDyslipidemiaInternational Journal of Cardiology
researchProduct

Reduction of HbA1c levels following nonsurgical treatment of periodontal disease in type 2 diabetics

2009

Objectives: A study was made of the effect of nonsurgical periodontal treatment upon blood glucose control in type 2 diabetics with periodontal disease. Study design: A pre-post repeated measures analytical design was used, with a PubMed search of the related articles published up until December 2008. Results: The improvement in glycosylated hemoglobin (HbA1c) after nonsurgical periodontal treatment on comparing the baseline (8.0290±1.5539) and final values (7.7806±1.5636) was 0.2483±0.1171, and proved statistically significant (p=0.042). Conclusions: A decrease in HbA1c was observed after treatment, thus indicating improved blood glucose control in type 2 diabetics with periodontal disease.

AdultMalemedicine.medical_specialtyPeriodontal treatmentGlucose controlDentistryHba1c levelPeriodontal diseaseInternal medicinemedicineHumansGeneral DentistryPeriodontal DiseasesAgedAged 80 and overGlycated Hemoglobinbusiness.industryRepeated measures designMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Nonsurgical treatmentDiabetes Mellitus Type 2OtorhinolaryngologyUNESCO::CIENCIAS MÉDICASFemaleSurgeryHemoglobinbusinessAfter treatment
researchProduct

Prevalence of myopic maculopathy in the German population: results from the Gutenberg health study.

2019

AimsTo determine the prevalence of myopic maculopathy in the general population in Germany and to analyse potential associations with ocular and systemic factors.DesignThe Gutenberg Health Study is a population-based study, including 15 010 participants aged 35–74 years.MethodsMyopic maculopathy was graded in phakic eyes with spherical equivalent ≤−6 D by assessing fundus photographs according to a recent international photographic classification system (META-PM). 801 eyes of 519 participants (mean age 51.0±0.77 years) met the conditions and had gradable fundus photographs. Age-specific prevalence estimates were computed. Multivariable logistic regression analysis was used to assess associa…

AdultMalemedicine.medical_specialtyRefractive errorgenetic structuresPopulationVisual AcuityBlood PressureFundus (eye)Logistic regressionRefraction Ocular03 medical and health sciencesCellular and Molecular NeuroscienceMacular Degeneration0302 clinical medicineAtrophyGerman populationOphthalmologyGermanyEpidemiologymedicineMyopiaPhotographyPrevalenceHumanseducationTriglyceridesAgedRetrospective StudiesGlycated Hemoglobineducation.field_of_studybusiness.industryMiddle Agedmedicine.diseaseeye diseasesSensory SystemsLipoproteins LDLOphthalmology030221 ophthalmology & optometryMaculopathyFemalesense organsbusinessLipoproteins HDL030217 neurology & neurosurgeryThe British journal of ophthalmology
researchProduct

Microcentrifuge or Automated Hematological Analyzer to Assess Hematocrit in Exercise? Effect on Plasma Volume Loss Calculations

2016

The assessment of plasma volume loss (∆PV) induced by exercise can be estimated from changes in hematocrit (Htc) and hemoglobin (Hb), and it is essential when investigating the metabolic or biologic response to exercise of circulating biomarkers. We aimed to ascertain whether the estimation of ∆PV may differ when Hb and Htc are determined by automated hematological analyzer (AHA) versus manual methods. Twenty-five healthy male subjects performed a maximal running incremental exercise. Blood samples were taken before exercise, immediately after exercise, and after a 30-min recovery. Hb and Htc (Htc-AHA) were determined by an AHA. Htc was also determined by microcentrifugation (Htc-M). The ∆P…

AdultMalemedicine.medical_specialtySpectrum analyzerSysmexAnalytical chemistryCentrifugationHematocritPlasma volumeIncremental exerciseHemoglobinsYoung Adult03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumanshemoconcentrationhealth care economics and organizationsplasma volumeAutomation LaboratoryexerciseBiologic responsemedicine.diagnostic_testChemistryDill and Costill equation030229 sport sciencesMiddle AgedhemoglobinHemoconcentrationDill and Costill equation; Sysmex; exercise; hemoconcentration; hemoglobin; plasma volumeHealthy Volunteersdigestive system diseasesComputer Science ApplicationsMedical Laboratory TechnologyCirculating biomarkersHematocritCardiologyHemoglobinBiomarkers030215 immunologySLAS Technology
researchProduct

Effect of consumption of a carob pod inositol-enriched beverage on insulin sensitivity and inflammation in middle-aged prediabetic subjects.

2016

This study assessed the effects of an inositol-enriched beverage (IEB) on blood glucose levels and inflammation status in subjects with an impaired fasting glucose (IFG) state according to body mass index (BMI). This was a 12 week, double-blind, randomized, controlled trial employing forty-four IFG subjects (fasting glucose levels 100-125 mg dl-1) that were divided into two intervention groups: one receiving a IEB (n = 24) containing mainly pinitol (2.0 g twice a day), and the other a sweetened beverage based on sucrose (SB; n = 20). Anthropometric and biochemical measurements, postprandial and fasting nocturnal glycaemia (continuous glucose monitoring system), and inflammatory parameters (…

AdultMalemedicine.medical_specialtySucrosemedicine.medical_treatment030209 endocrinology & metabolism030204 cardiovascular system & hematologyGalactansBeveragesMannansPrediabetic State03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInsulin resistanceDouble-Blind MethodInternal medicinePlant GumsmedicineHumansAgedGlycated HemoglobinInflammationPinitolbusiness.industryInsulinGeneral MedicineAnthropometryMiddle AgedImpaired fasting glucosemedicine.diseaseEndocrinologyPostprandialchemistryFemaleInsulin ResistancebusinessBody mass indexInositolFood ScienceFoodfunction
researchProduct

Pioglitazone in addition to metformin improves erythrocyte deformability in patients with Type 2 diabetes mellitus

2010

The aim of the present study was to compare the effect of PIO (pioglitazone) or GLIM (glimepiride) on erythrocyte deformability in T2DM (Type 2 diabetes mellitus). The study covered 23 metformin-treated T2DM patients with an HbA1c (glycated haemoglobin) >6.5%. Patients were randomized to receive either PIO (15 mg, twice a day) or GLIM (1 mg, twice a day) in combination with metformin (850 mg, twice a day) for 6 months. Blood samples were taken for the measurement of fasting glucose, HbA1c, fasting insulin, intact proinsulin, adiponectin and Hct (haematocrit). In addition, the erythrocyte EI (elongation index) was measured using laser diffractoscopy. Both treatments significantly impr…

AdultMalemedicine.medical_specialtyendocrine system diseasesmedicine.medical_treatmentType 2 diabetesInsulin resistanceErythrocyte DeformabilityInternal medicineDiabetes mellitusHumansHypoglycemic AgentsMedicineAgedProinsulinGlycated HemoglobinPioglitazoneAdiponectinbusiness.industryInsulinnutritional and metabolic diseasesGeneral MedicineMiddle Agedmedicine.diseaseMetforminGlimepirideSulfonylurea CompoundsEndocrinologyDiabetes Mellitus Type 2Drug Therapy CombinationFemaleThiazolidinedionesStress MechanicalbusinessPioglitazonemedicine.drugClinical Science
researchProduct

Increase in Nocturnal Blood Pressure and Progression to Microalbuminuria in Type 1 Diabetes

2002

Patients with type 1 diabetes mellitus and microalbuminuria often have elevated blood pressure while they are asleep, but it is not known whether the elevation develops concomitantly with microalbuminuria or precedes it.We monitored 75 adolescents and young adults who had had type 1 diabetes with normal urinary albumin excretion and blood pressure for more than five years. Ambulatory blood-pressure monitoring was used to assess blood pressure at the initial evaluation and about two years later, at which time all subjects had normal urinary albumin excretion. Subsequently, subjects were monitored for the development of microalbuminuria.Microalbuminuria developed in 14 subjects, whereas the o…

Adultmedicine.medical_specialtyAdolescentBlood PressureExcretionInternal medicineDiabetes mellitusmedicineAlbuminuriaHumansProspective StudiesGlycated HemoglobinType 1 diabetesProteinuriabusiness.industryAlbuminGeneral MedicineBlood Pressure Monitoring Ambulatorymedicine.diseaseCircadian RhythmDiabetes Mellitus Type 1EndocrinologyBlood pressureAmbulatoryDisease ProgressionCardiologyMicroalbuminuriamedicine.symptombusinessBiomarkersNew England Journal of Medicine
researchProduct